SLCO4A1-AS1 promotes colorectal tumourigenesis by regulating Cdk2/c-Myc signalling.
SLCO4A1-AS1 promotes colorectal tumourigenesis by regulating Cdk2/c-Myc signalling.
复制标题
SLCO4A1-AS1通过调节Cdk2/c-Myc信号传导促进结直肠肿瘤的发生。
DOI:
10.1186/s12929-022-00789-z
复制
发表时间:
2022-01-17
影响因子:
11
通讯作者:
Huang Z
中科院分区:
文献类型:
--
作者:
Zhang J;Cui K;Huang L;Yang F;Sun S;Bian Z;Wang X;Li C;Yin Y;Huang S;Zhou L;Fei B;Huang Z
SLCO4A1-AS1 was found to be upregulated in several cancer types, including colorectal cancer (CRC). However, the detailed roles of SLCO4A1-AS1 in CRC remain to be elucidated. Therefore, we investigated the functions, mechanism, and clinical significance of SLCO4A1-AS1 in colorectal tumourigenesis. We measured the expression of SLCO4A1-AS1 in CRC tissues using qRT-PCR and determined its correlation with patient prognosis. Promoter methylation analyses were used to assess the methylation status of SLCO4A1-AS1. Gain- and loss-of-function assays were used to evaluate the effects of SLCO4A1-AS1 on CRC growth in vitro and in vivo. RNA pull-down, RNA immunoprecipitation, RNA-seq, luciferase reporter and immunohistochemistry assays were performed to identify the molecular mechanism of SLCO4A1-AS1 in CRC. SLCO4A1-AS1 was frequently upregulated in CRC tissues based on multiple CRC cohorts and was associated with poor prognoses. Aberrant overexpression of SLCO4A1-AS1 in CRC is partly attributed to the DNA hypomethylation of its promoter. Ectopic SLCO4A1-AS1 expression promoted CRC cell growth, whereas SLCO4A1-AS1 knockdown repressed CRC proliferation both in vitro and in vivo. Mechanistic investigations revealed that SLCO4A1-AS1 functions as a molecular scaffold to strengthen the interaction between Hsp90 and Cdk2, promoting the protein stability of Cdk2. The SLCO4A1-AS1-induced increase in Cdk2 levels activates the c-Myc signalling pathway by promoting the phosphorylation of c-Myc at Ser62, resulting in increased tumour growth. Our data demonstrate that SLCO4A1-AS1 acts as an oncogene in CRC by regulating the Hsp90/Cdk2/c-Myc axis, supporting SLCO4A1-AS1 as a potential therapeutic target and prognostic factor for CRC. The online version contains supplementary material available at 10.1186/s12929-022-00789-z.
登录
查看更多内容
影响因子:
4.6
作者:
Bian Z;Jin L;Zhang J;Yin Y;Quan C;Hu Y;Feng Y;Liu H;Fei B;Mao Y;Zhou L;Qi X;Huang S;Hua D;Xing C;Huang Z
通讯作者:
Huang Z
DOI:
10.1186/s13046-020-01783-9
发表时间:
2020-12-02
期刊:
Journal of experimental & clinical cancer research : CR
影响因子:
--
作者:
Hu XT;Xing W;Zhao RS;Tan Y;Wu XF;Ao LQ;Li Z;Yao MW;Yuan M;Guo W;Li SZ;Yu J;Ao X;Xu X
通讯作者:
Xu X
影响因子:
37.3
作者:
Augoff K;McCue B;Plow EF;Sossey-Alaoui K
通讯作者:
Sossey-Alaoui K
DOI:
10.1038/s41374-021-00577-7
发表时间:
2021-07
期刊:
Laboratory investigation; a journal of technical methods and pathology
影响因子:
--
作者:
Wu K;Xu T;Song X;Shen J;Zheng S;Zhang L;Tao G;Jiang B
通讯作者:
Jiang B
DOI:
10.1007/978-1-4939-2425-7_25
发表时间:
2015-01-01
期刊:
PROTEIN-PROTEIN INTERACTIONS: METHODS AND APPLICATIONS, 2ND EDITION
影响因子:
--
作者:
Takahashi, Yoshinori
通讯作者:
Takahashi, Yoshinori